Platform Overview

What PanAum Delivers

A unified computational ecosystem that bridges the gap between target identification and clinical-grade drug design. PanAum transforms static targets into dynamic, population-characterized therapeutic assets — multi-omics, network biology, pharmacogenomics, and generative chemistry in one automated workflow.

01

Multi-Omics Integration

Whole Genome Sequencing, Proteomics, and Epigenomics layers combined for deep biological context.

02

Network Centrality Analysis

Five advanced metrics (Degree, Betweenness, Closeness, Eigenvector, and PageRank) for rigorous target scoring.

03

Pharmacogenomics Layer

Population-level variant profiling built into every stage, from target selection through to the final clinical report.

04

4 Therapeutic Modalities

Specialized workflows for Small Molecules, Antibodies, PROTACs, and Novel Target classes.

Explore the End-to-End Pipeline

Six automated stages from evidence input to executive-ready reporting, with full scientific provenance throughout.

See the Pipeline →